Management Options for Constipation
The first-line treatment for constipation is polyethylene glycol (PEG) 3350 at a dosage of 17g dissolved in 8oz of water once daily, which has moderate certainty of evidence for effectiveness and a favorable safety profile. 1
Pharmacological Management
First-Line Options
- Osmotic Laxatives
Second-Line Options
- Stimulant Laxatives
- Senna (8.6-17.2mg) or bisacodyl (5-10mg) at bedtime 1
- Particularly useful when osmotic laxatives alone are insufficient
For Opioid-Induced Constipation
- Naldemedine: 0.2mg daily (strong evidence for achieving ≥3 spontaneous bowel movements/week) 1
- Naloxegol: Recommended with moderate-quality evidence 1
- Methylnaltrexone: 0.15mg/kg subcutaneously every other day (no more than once daily); useful when oral medications cannot be used 1
- Lubiprostone: 24mcg twice daily with food; use with caution in patients taking methadone 1
- Note: PAMORAs (peripherally acting mu-opioid receptor antagonists) are contraindicated in patients with gastrointestinal perforation risk or mechanical bowel obstruction 1
Novel Agents
- Plecanatide: FDA-approved for chronic idiopathic constipation; acts as a guanylate cyclase-C agonist in the GI tract with minimal systemic absorption 2
Lifestyle Modifications
Dietary Changes
- Gradually increase dietary fiber to 20-25g per day, focusing on soluble fiber 1
- Increase fluid intake to at least 8 glasses of water daily 1
- Consider mineral water rich in magnesium and/or bicarbonate 3
Physical Activity
- Increase physical activity within patient limits 1
- Aim for at least 30 minutes of exercise per day to alleviate symptoms 4
Toileting Habits
- Optimize toileting habits:
Assessment and Monitoring
Initial Evaluation
Evaluate for red flag symptoms:
- Rectal bleeding
- Unintentional weight loss
- Change in stool caliber
- Progressive abdominal pain 1
Physical examination:
- Abdominal examination
- Perineal inspection
- Digital rectal examination to assess for fecal impaction 1
Monitoring Treatment Response
- Reassess treatment efficacy within 2-4 weeks of initiating therapy 1
- Goal: One non-forced bowel movement every 1-2 days 1
- Use the Bowel Function Index to assess severity and monitor response:
- Score ≥30 indicates clinically significant constipation requiring escalation of therapy 1
Special Situations
Fecal Impaction
- Consider rectal interventions:
- Glycerine suppositories
- Rectal bisacodyl twice daily
- Manual disimpaction if necessary 1
Types of Constipation and Specific Approaches
- Slow Transit Constipation: May require laxative therapy beyond fiber and increased activity 5
- Pelvic Floor Dysfunction/Dyssynergic Defecation: Biofeedback therapy and pelvic muscle re-education 5
- Constipation-predominant IBS: Dietary monitoring and modifications, fiber therapy, and patient education 5
Important Caveats and Pitfalls
- Docusate has not shown benefit and is not recommended 1
- Using fiber supplements in patients with severe constipation or suspected obstruction is not recommended 1
- Continuing ineffective treatments without reassessment is not recommended 1
- Using PAMORAs as first-line treatment is not recommended 1
- Common side effects of PEG include diarrhea, abdominal distension, flatulence, and nausea, which are typically mild to moderate 1
- Bloating and flatulence are common side effects of highly fermentable fibers 4
- Conservative treatment (lifestyle modifications alone) is usually insufficient and should be supplemented with laxatives or motility-enhancing drugs 4